Patent · US Active

Selective AT2 receptor agonists for use in treatment of cachexia

US10016397B2 · kind B2 · utility

2Cited by

2References

20Claims

0Family size

Assignee

CHARITÉ—UNIVERSITÄTSMEDIZIN BERLIN · DE

Inventors

Jochen Springer · Falkensee, DE
Stefan Anker · Berlin, DE
Andrew JS Coats · Norwich, GB

Key dates

Filing date	Jul 17, 2014
Grant date	Jul 10, 2018
Priority date	—
Expiry date	Jul 17, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to selective AT2 receptor agonist or a pharmaceutically acceptable salt thereof for use in treatment of cachexia, preferably for use in treatment of cancer cachexia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.